Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Revive Therapeutics Ltd (RVVTF)

Revive Therapeutics Ltd (RVVTF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade RVVTF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2940 +23.50%
on 09/02/21
0.4238 -14.32%
on 09/10/21
+0.0441 (+13.82%)
since 08/20/21
3-Month
0.2751 +31.99%
on 08/11/21
0.5100 -28.80%
on 07/07/21
-0.0447 (-10.96%)
since 06/21/21
52-Week
0.1280 +183.67%
on 10/30/20
0.7200 -49.57%
on 12/14/20
+0.1683 (+86.40%)
since 09/21/20

Most Recent Stories

More News
Revive Therapeutics Included in AdvisorShares(R) Newly Launched Psychedelics ETF

Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs...

RVVTF : 0.3631 (+3.15%)
RVV.CN : 0.460 (+6.98%)
PSIL : 9.62 (+0.96%)
Proactive news headlines including Globex Data, Revive Therapeutics, Mirasol Resources and Mydecine Innovations

Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies

MRZLF : 0.3050 (+7.55%)
RVVTF : 0.3631 (+3.15%)
Revive Therapeutics Signs Exclusive Worldwide License Agreement For Medicinal Mushroom Ganoderma Lucidum To Treat Cancer

Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs...

RVVTF : 0.3631 (+3.15%)
RVV.CN : 0.460 (+6.98%)
Revive Confirms No Material Undisclosed Information

Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (Frankfurt:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs...

RVVTF : 0.3631 (+3.15%)
RVV.CN : 0.460 (+6.98%)
Revive Therapeutics Provides Update on Psychedelics Clinical Product Pipeline

Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs...

RVVTF : 0.3631 (+3.15%)
RVV.CN : 0.460 (+6.98%)
PHRRF : 0.6440 (+3.60%)
PHRM.CN : 0.810 (+2.53%)
IIROC Trade Resumption - RVV

COMTEX_389872705/2669/2021-07-15T13:50:09

RVVTF : 0.3631 (+3.15%)
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs...

RVVTF : 0.3631 (+3.15%)
RVV.CN : 0.460 (+6.98%)
The Digital Transformation of Healthcare Creating Substantial Opportunity

Demand for digital health technology is on the rise. According to Digital Authority Partners, “Telemedicine, ...

RVV.CN : 0.460 (+6.98%)
RVVTF : 0.3631 (+3.15%)
MYCOF : 0.2758 (-1.50%)
EPWCF : 0.3311 (-3.64%)
DOC.VN : 1.630 (-0.61%)
DOCRF : 1.2650 (-0.84%)
AIMLF : 0.5378 (-5.02%)
DOC.CN : 2.065 (+190.85%)
CBDT.CN : 0.430 (-3.37%)
AIML.CN : 0.690 (-1.43%)
Revive Therapeutics Approved to Trade on the OTCQB Market

Revive Therapeutics Ltd. ("Revive" or the "Company") (CSE: RVV, USA: RVVTF, FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs...

RVV.CN : 0.460 (+6.98%)
RVVTF : 0.3631 (+3.15%)
Revive Collaborates With University of Health Sciences Antigua To Pioneer Clinical Research of Psychedelics

Revive Therapeutics Ltd. ("Revive" or the "Company") (CSE: RVV, USA: RVVTF, Frankfurt: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs...

RVV.CN : 0.460 (+6.98%)
RVVTF : 0.3631 (+3.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.4459
2nd Resistance Point 0.4141
1st Resistance Point 0.3886
Last Price 0.3631
1st Support Level 0.3313
2nd Support Level 0.2995
3rd Support Level 0.2740

See More

52-Week High 0.7200
Fibonacci 61.8% 0.4939
Fibonacci 50% 0.4240
Last Price 0.3631
Fibonacci 38.2% 0.3541
52-Week Low 0.1280

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar